Gf Fund Management Co. Ltd. Centessa Pharmaceuticals PLC Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 2,283 shares of CNTA stock, worth $29,679. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,283
Previous 1,872
21.96%
Holding current value
$29,679
Previous $31.4 Million
4.7%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CNTA
# of Institutions
142Shares Held
124MCall Options Held
163KPut Options Held
816K-
Medicxi Ventures Management (Jersey) LTD20MShares$260 Million75.25% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$130 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$126 Million4.7% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.95MShares$90.4 Million0.19% of portfolio
-
Janus Henderson Group PLC London, X05.92MShares$77 Million0.05% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.23B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...